These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24048594)

  • 1. Illegitimate companies threaten patients' receipt of FDA-approved drugs.
    Thompson CA
    Am J Health Syst Pharm; 2013 Oct; 70(19):1646-7. PubMed ID: 24048594
    [No Abstract]   [Full Text] [Related]  

  • 2. Deterring the importation of counterfeit pharmaceutical products.
    Stearn DW
    Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
    [No Abstract]   [Full Text] [Related]  

  • 3. Counterfeit drugs.
    Rudolf PM; Bernstein IB
    N Engl J Med; 2004 Apr; 350(14):1384-6. PubMed ID: 15070787
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmaceuticals and medical devices: business practices. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-36. PubMed ID: 23297448
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA chief attacks Canada's drug price controls.
    Webster P
    Lancet; 2003 Nov; 362(9398):1816. PubMed ID: 14661624
    [No Abstract]   [Full Text] [Related]  

  • 6. Selling drug samples lands doctor in prison.
    Nordenberg T
    FDA Consum; 1998; 32(2):39. PubMed ID: 9532957
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceuticals and medical devices: business practices.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
    [No Abstract]   [Full Text] [Related]  

  • 8. Bitter pills for drug companies.
    Newman M
    BMJ; 2010 Sep; 341():c5095. PubMed ID: 20851842
    [No Abstract]   [Full Text] [Related]  

  • 9. Market watch: Top drugs and companies by sales in 2017.
    Urquhart L
    Nat Rev Drug Discov; 2018 Mar; 17(4):232. PubMed ID: 29588516
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting drug companies' bottom line.
    Prescrire Int; 2011 Jan; 20(112):25. PubMed ID: 21462792
    [No Abstract]   [Full Text] [Related]  

  • 11. Top 100 bestselling drugs represent an arena struggling for new FDA approvals: drug age as an efficiency indicator.
    Polanski J; Bogocz J; Tkocz A
    Drug Discov Today; 2015 Nov; 20(11):1300-4. PubMed ID: 26160060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceuticals and medical devices: cost savings. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-33. PubMed ID: 23297446
    [No Abstract]   [Full Text] [Related]  

  • 13. An uncertain future for cardiovascular drug development?
    Garber AM
    N Engl J Med; 2009 Mar; 360(12):1169-71. PubMed ID: 19297568
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceuticals and Medical Devices: Business Practices.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-38. PubMed ID: 28252886
    [No Abstract]   [Full Text] [Related]  

  • 15. Show drugs work before selling them.
    Sipp D; McCabe C; Rasko JE
    Nature; 2017 Mar; 543(7644):174-175. PubMed ID: 28277530
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparing patient access to pharmaceuticals in the UK and US.
    Cohen J; Cairns C; Paquette C; Faden L
    Appl Health Econ Health Policy; 2006; 5(3):177-87. PubMed ID: 17132032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Europe clamps down on illegal trade of drugs donated for the poor.
    Kolfschooten Fv
    Lancet; 2002 Nov; 360(9344):1486. PubMed ID: 12433526
    [No Abstract]   [Full Text] [Related]  

  • 18. RFID implementation not moving fast enough, FDA says.
    Young D
    Am J Health Syst Pharm; 2006 Mar; 63(6):500-2. PubMed ID: 16522876
    [No Abstract]   [Full Text] [Related]  

  • 19. Balancing government regulation against access to drugs: address to Seton Hall University School of Law, February 16, 2007.
    Meron D
    Seton Hall Law Rev; 2007; 37(4):929-39. PubMed ID: 18363219
    [No Abstract]   [Full Text] [Related]  

  • 20. Bad medicine in the market.
    Roger B; Boateng K
    World Hosp Health Serv; 2007; 43(3):17-21. PubMed ID: 18269104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.